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Abstract
Activity-dependent synaptic plasticity is known to be important in learning and memory, persistent
pain and drug addiction. Glutamate NMDA receptor activation stimulates several protein kinases,
which then trigger biochemical cascades that lead to modifications in synaptic efficacy. Genetic and
pharmacological techniques have been used to show a role for Ca2+/calmodulin-dependent kinase
II (CaMKII) in synaptic plasticity and memory formation. However, it is not known if increasing
CaMKII activity in forebrain areas affects behavioral responses to tissue injury. Using genetic and
pharmacological techniques, we were able to temporally and spatially restrict the over expression
of CaMKII in forebrain areas. Here we show that genetic overexpression of CaMKII in the mouse
forebrain selectively inhibits tissue injury-induced behavioral sensitization, including allodynia and
hyperalgesia, while behavioral responses to acute noxious stimuli remain intact. CaMKII
overexpression also inhibited synaptic depression induced by a prolonged repetitive stimulation in
the ACC, suggesting an important role for CaMKII in the regulation of cingulate neurons. Our
results suggest that neuronal CaMKII activity in the forebrain plays a role in persistent pain.
Introduction
Ca2+/calmodulin-dependent kinase II (CaMKII) is a key
molecule involved in regulating glutamatergic synaptic
transmission and learning and memory [1,2]. Several
lines of evidence support a role for CaMKII in synaptic
plasticity and memory (see [2] for review). The ability of
CaMKII to autophosphorylate, which prolongs activation
in a CaM independent manner, supports an important
role for CaMKII in synaptic plasticity [2]. A point muta-
tion in the CaMKII gene that blocks autophosphorylation
abolished LTP and impaired spatial memory in mice [3].
While the autophosphorylation and dephosphorylation
of CaMKII support the hypothesis that it can act as a
"molecular switch" in plasticity and memory, recent stud-
ies favor a more sophisticated frequency-dependent
biphasic modulation of CaMKII in learning-related syn-
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apses. Transgenic mice that overexpress a calcium inde-
pendent form of CaMKII in forebrain areas demonstrated
a shift of frequency-dependent responses to repetitive
stimulation [4]. Consistently, these mice displayed an
impairment in spatial memory [5]. The role of CaMKII in
central synaptic plasticity is not limited to the hippocam-
pus and spatial memory. In the cortex, αCaMKII activity
plays a role in long-term or permanent memory and cor-
tical LTP [6,7].
Glutamatergic synapses involved in sensory transmission
can undergo learning-like plastic changes [8-11]. Long-
term changes in plasticity along sensory transmission
pathways, including the spinal cord dorsal horn and cor-
tical neurons, have been reported [12,13]. A role for CaM-
KII in experience-dependent plasticity was shown in the
spinal cord dorsal horn, and spinal CaMKII is involved in
the development of persistent pain [14,15]. However, no
study has determined if forebrain CaMKII plays a role in
the development of persistent pain. The present study
takes advantage of recently developed CaMKII transgenic
mice that use genetic and chemical techniques to spatially
and temporally restrict the expression of CaMKII [16], We
tested if the overexpression of CaMKII in the forebrain
affected neuronal properties and synaptic plasticity in the
anterior cingulate cortex (ACC), and then carried out
behavioral studies to see if responses to peripheral nox-
ious stimuli and tissue injury were affected in forebrain
CaMKII overexpressing mice. Synaptic plasticity in the
ACC may serve as a cellular model for studying the roles
of CaMKII in forebrain structures and behavioral alterna-
tions to persistent pain may be due to changes in these
forebrain neurons.
Methods
Animals
CaMKII F89G transgenic male mice (8–12 weeks) were
provided by Dr. Tsien's lab (see [16]). The transgene
founders were produced by pronuclear injection of linear-
ized DNA into B6/CBA F1 zygotes, and then intercrossed
with B6/CBAF1. The CaMKII F89G transgene expression
vector was constructed by inserting the 2.8-kb NotI frag-
ment of the CaMKII F89G transgene into the unique NotI
site of pMM279 containing a 8.5-kb CaMKII promotor
sequence. Genotyping of the CaMKII F89G transgene was
conducted by PCR. Both wild-type and transgenic mice
were well groomed and showed no signs of abnormality
or any obvious motor defects. As it was impossible to vis-
ually distinguish between transgenic and wild-type mice,
experimenters were blind to the genotype. The experimen-
tal protocols were approved by the Animal Studies Com-
mittee at Washington University and University of
Toronto.
Slice electrophysiology
Transverse slices of the ACC were rapidly prepared and
maintained in an interface chamber at 28°C, where they
were subfused with artificial cerebrospinal fluid (ACSF)
consisting of (in mM) 124 NaCl, 4.4 KCl, 2.0 CaCl2, 1.0
MgSO4, 25 NaHCO3, 1.0 Na2HPO4, and 10 glucose, bub-
bled with 95% O2 and 5% CO2. Slices were kept in the
recording chamber for at least two hr prior to the start of
experiments. A bipolar tungsten stimulating electrode was
placed in layer V of the ACC, and extracellular field poten-
tials were recorded using a glass microelectrode (3–12
MΩ, filled with ACSF) placed in layer II/III. Five trains of
theta burst stimulation (TBS), which consisted of five
bursts (four pulses at 100 Hz) of stimuli delivered every
200 ms at the same intensity, were applied to induce LTP.
A low-frequency, prolonged stimulation (1 Hz, 15 min)
was used to induce LTD. Synaptic responses were elicited
at 0.02 Hz. In some experiments, intracellular recordings
were also performed with glass microelectrodes filled with
2% Neurobiotin-2 M potassium chloride (80–200 MΩ).
After electrophysiological characterization, cells were
injected with neurobiotin (+3.0 nA, 150 ms, 3.3 Hz for 5
min). The slices then fixed in 4% paraformaldehyde 30
min after the injection. Morphological procedures were
used to stain and identify the recorded cells.
Acute behavioral responses to noxious stimuli
The tail-flick reflex was evoked by focused, radiant heat
applied to underside of the tail. The latency to reflexive
removal of the tail away from the heat was measured by a
photocell timer to the nearest 0.1 sec. The hot-plate (HP)
reflex was measured on a metal plate at 55°C (Columbia
Instruments). Nociceptive responses included licking or
lifting of a hindpaw, or jumping. All mice showed
responses within 20 sec. They were removed from the
chamber immediately after the first response. In some
experiments, the HP response was measured at different
temperatures (50 or 52°C). All behavioral tests were per-
formed at 10 min intervals. The baseline response latency
was an average of three or four measurements.
Inflammatory pain and measurement of allodynia/
hyperalgesia
Formalin (5%, 10 µl) was injected subcutaneously into
the dorsal side of a hind paw. The total time spent licking
or biting the injected hind paw was recorded and averaged
for each 5 min interval over the course of 2 hr. For inflam-
matory pain, complete Freund's adjuvant (CFA, 50% in
saline, 10 µl; Sigma) was injected into the dorsal surface
of the left hind paw. After 24 h and 72 h, animals were
placed in individual plastic boxes and allowed to adjust to
the environment for 1 h. Using the up-down paradigm,
mechanical sensitivity was assessed with a set of von Frey
filaments (Stoelting; Wood Dale, Illinois) modified so
that the filament extended in parallel to the rod. The up-Molecular Pain 2006, 2:21 http://www.molecularpain.com/content/2/1/21
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down paradigm method was used to determine the
mechanical threshold. For the measurement of mechani-
cal allodynia, based on preliminary experiments that char-
acterized the threshold stimulus, the No. 2.44 filament
(0.036 gm force) innocuous for untreated wild-type
mouse but representing 50% of the threshold force in ani-
mals with injection of CFA, was used to detect mechanical
allodynia [16,18]. The filament was applied to the point
of bending 6 times each to the dorsal surfaces of the left
and right hindpaws. Positive responses included pro-
longed hindpaw withdrawal followed by licking or
scratching. For each time point, the percent response fre-
quency of hindpaw withdrawal was expressed as (number
of positive responses)/6 × 100 per hindpaw.
Heat hyperalgesia was measured by recording the with-
drawal latency of a single hind paw from a radiant heat
source (IITC Life Sciences instrument, Woodland Hills,
Calif). Mice were placed in Plexiglas restrainers on an ele-
vated platform with a clear glass top. A radiant heat source
with an "active intensity" of 30 (active intensity is the
intensity of light source as coined by the manufacturer)
was used as the stimulus. The heat source was positioned
on the plantar skin of a hind paw. A built in timer starts
when the light beam is switched on. When the animal
withdrew its paw abruptly, the heat source and the timer
were stopped simultaneously. The duration in seconds
from the start of heat application to the paw withdrawal
was measured as the paw withdrawal latency.
Pharmacology and drug administration
Chemical synthesis and tritiation of 1-Naphthylmethyl
(1NM-PP1) was described previously [16]. Briefly, the
ATP-binding pocket of αCaMKII kinase was enlarged via
silent mutation. 1NM-PP1 was designed to fit only this
enlarged pocket and not the unmodified pocket of native
αCaMKII. By using αCaMKII promoter-driven construct,
we were able to selectively over express αCaMKII in fore-
brain neurons. The over expressed αCaMKII-F89G activity
could be inhibited by noninvasive oral intake of 1NM-
PP1 (5 µM in drinking water) for more than 24 hours (see
[14]). The complete inhibition of αCaMKII-F89G activity
can be maintained as long as the 1NM-PP1-containing
water is provided. In some experiments, slices from wild-
type littermates taking 1NM-PP1-containing drinking
water were used as controls.
Data analysis
Data are presented as the mean ± SEM. Statistical compar-
isons were made with the use of analyses of variance
(ANOVAs: Newman-Keuls tests for post hoc comparison)
or Student's t-test. P < 0.05 was considered significant.
Results
In general, αCaMKII-F89G transgenic (Tg) mice were vis-
ually indistinguishable from wild-type mice. Our previ-
ous study used biochemical and pharmacological
techniques to screen five different lines of transgenic mice,
and the CaMKII Tg-1 line was found to have the highest
transgenic mRNA expression. CaMKII overexpression was
limited to the forebrain areas, including the ACC, hippoc-
ampus, and amygdala, using a αCaMKII promoter-driven
construct (see Methods and [14]). No CaMKII overexpres-
sion was detected in the hindbrain or spinal cord [16].
Furthermore, biochemical experiments showed that cal-
cium-dependent CaMKII activity was increased by 2.6 fold
in transgenic mice compared to wild-type mice. No
changes in other protein kinase such as β CaMKII or CaM-
KIV were found. Administration of 0.5 µM 1NM-PP1 (a
compound that inhibits transgenic CaMKII, see methods)
in vitro or systemic application of 1NM-PP1 in Tg-1 mice
was found to inhibit overexpressed activity without effect-
ing basal CaMKII in wild-type mice. Thus we chose to use
the Tg-1 line of transgenic αCaMKII-F89G mice in the
present study.
We first performed anatomical experiments in wild-type
and αCaMKII-F89G transgenic mice to check whether the
gross development of several sensory related brain areas
were affected. Analysis of serial coronal sections, exam-
ined by light microscopy, showed no visual detectable
morphological differences in the ACC, insular cortex,
brainstem, and spinal dorsal horn between CaMKII Tg
and WT mice (Fig. 1). Next we asked whether the neuro-
nal spiking properties of ACC neurons might be affected
in the transgenic mice. We performed intracellular record-
ings from ACC neurons (Fig. 2A–C). Similar to results
found in the hippocampus, we did not find any signifi-
cant changes in baseline synaptic responses in ACC neu-
rons (wild-type, n = 16 neurons/10 mice; transgenic, n =
10 neurons/6 mice). No significant changes were
observed in neuronal spiking in response to direct current
injection (wild-type, n = 12 neurons/8 mice; transgenic, n
= 9 neurons/6 mice). Resting membrane potentials were
identical between cells recorded from wild-type (n = 14
neurons/10 mice) and transgenic mice (n = 12 neurons/6
mice). Furthermore, the current threshold for eliciting the
first spike was similar in ACC neurons from wild-type and
transgenic mice (n = 3–6 neurons for each group) and the
number of spiking induced by injection of 0.3 nA was also
identical (n = 6–10 cells). These results indicate that
αCaMKII overexpression did not cause changes in the
intrinsic neuronal electrophysiological properties of ACC
neurons.
CaMKII activity is important for synaptic plasticity. In a
previous study of αCaMKII-F89G transgenic mice, we
found that αCaMKII overexpression selectively affectedMolecular Pain 2006, 2:21 http://www.molecularpain.com/content/2/1/21
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Brain morphology of wild-type and αCaMKII-F89G transgenic mice Figure 1
Brain morphology of wild-type and αCaMKII-F89G transgenic mice. Coronal sections showed no detectable mor-
phological differences in the ACC, insular cortex, rostroventral medulla (RVM) and spinal cord dorsal horn. Scale bar: 250 µm 
(ACC, insular cortex and RVM), and 100 µm (spinal dorsal horn).Molecular Pain 2006, 2:21 http://www.molecularpain.com/content/2/1/21
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the frequency-response relationship of synaptic plasticity
in the CA1 region of the hippocampus [16]. In addition to
enhanced LTP induced by strong tetanic stimulation, syn-
aptic responses in response to repetitive stimulation at
lower frequencies were also altered [16]. To study if cingu-
late plasticity may also be affected in these mice, we
decided to investigate both LTP and LTD in ACC slices of
wild-type and transgenic mice. We did not detect changes
Comparison of neuronal properties in wild-type and αCaMKII-F89G transgenic mice Figure 2
Comparison of neuronal properties in wild-type and αCaMKII-F89G transgenic mice. A. Evoked synaptic 
responses recorded to focal stimulation in the ACC of wild-type and αCaMKII-F89G transgenic mice. B. Action potentials of 
ACC neurons from wild-type and αCaMKII-F89G transgenic mice. C. Resting membrane potentials from ACC neurons of 
wild-type and αCaMKII-F89G transgenic mice. Note: no significant difference was found between wild-type and αCaMKII-F89G 
transgenic mice.Molecular Pain 2006, 2:21 http://www.molecularpain.com/content/2/1/21
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in synaptic potentiation induced by theta burst stimula-
tion in ACC slices of transgenic mice (mean 157.2 ±
20.4% of control; n = 6 slices/5 mice) as compared to
wild-type mice (mean 167.2 ± 12.8% of control, n = 12
slices/10 mice; P = 0.346) (Fig. 3C). To detect possible
changes in frequency-dependent responses, we examined
the effect of prolonged repetitive stimulation in cingulate
slices. We previously showed that low-frequency repeti-
tive stimulation at 1 Hz for 15 min induced LTD in the
ACC of adult rats [9]. Furthermore, repetitive stimulation
at 3 or 5 Hz stimulation also induced LTD of synaptic
responses in ACC slices [9]. As shown in Fig. 3B, we found
that 1 Hz stimulation (15 min) induced robust LTD in the
ACC of wild-type mice (8–12 weeks old) (mean 35.7 ±
14.1%, n = 6 slices/6 mice, P < 0.05 compared with base-
line). Similar to ACC in adult rats, 5 Hz stimulation for 3
min also produced long-lasting depression of synaptic
responses in ACC slices (mean 39.1 ± 5.5%, n = 5 slices/5
mice; P < 0.001 as compared with baseline) (Fig. 3D). We
then tested if forebrain overexpression of CaMKII affects
synaptic LTD in the ACC. As shown in Figure 3B, we
found that LTD induced by 1 Hz stimulation (15 min)
was significantly reduced or completely abolished in
transgenic mice (mean 84.4 ± 10.7%, n = 6 slices/6 mice;
P < 0.01 as compared with LTD in wild-type mice). Simi-
larly, in transgenic mice, 5 Hz stimulation did not induce
any synaptic depression (mean 102.3 ± 8.9%, n = 5 slices/
5 mice, Fig. 3; P < 0.001 as compared with wild-type mice)
(Fig. 3D).
Results described above indicate that overexpressing CaM-
KII in the forebrain causes selective changes in synaptic
LTD without causing any obvious anatomical abnormal-
ity or change in neuronal excitability. These findings sug-
gest that αCaMKII-F89G transgenic mice may serve as an
excellent model for investigating the role of CaMKII in
forebrain plasticity. Since forebrain structures play a key
role in sensory perception and plasticity, we next wanted
to determine if forebrain CaMKII plays a role in behavio-
ral responses to sensory stimuli and injury. To study the
behavioral responses to acute noxious stimuli, we per-
formed the tail-flick and hot-plate tests. We found that
behavioral responses to noxious thermal stimuli were
similar between wild-type and transgenic mice (Fig. 4,
tail-flick test: wild-type, n = 6 mice; transgenic mice, n = 7
mice; thermal withdrawal: wild-type, n = 10 mice, trans-
genic mice, n = 6 mice), indicating that enhanced CaMKII
activity in the forebrain did not significantly affect acute
behavioral responses to noxious stimuli. To detect possi-
ble temperature-dependent changes in hot-plate
responses, we measured responses at additional tempera-
tures (50 and 52°C). Again, we did not find any signifi-
cant difference (n = 12 mice for wild-type mice, n = 11 for
transgenic mice) (Fig. 4B). We also measured hindpaw
withdrawal to mechanical pressure and found that
mechanical withdrawal thresholds were not affected in
transgenic mice (n = 4 mice for each group, Fig. 4D).
These results consistently demonstrate that behavioral
responses to acute noxious thermal and mechanical stim-
uli were not affected by enhanced forebrain CaMKII activ-
ity.
NMDA receptors and their related signaling pathways in
the forebrain (including the ACC) have been implicated
in injury-related behavioral sensitization [17-19]. Thus, it
is possible that CaMKII contributes to behavioral
responses to tissue injury and inflammation, a long-last-
ing form of behavioral sensitization. The formalin test
measures spontaneous responses to tissue injury and
inflammation [17,20]. Formalin-induced behavioral
responses consist of three phases and depend on NMDA
receptors at different levels of the brain [10,21]. We tested
formalin-induced nociceptive responses in wild-type and
CaMKII transgenic mice and found that all the three
phases did not differ between transgenic (n = 7 mice) and
wild-type (n = 13 mice) mice (Fig. 4E). In animals with
persistent pain, behavioral sensitization to non-noxious
stimuli or mechanical allodynia happens after tissue
injury. We next tested the role of enhanced CaMKII activ-
ity in the development of allodynia induced by a hind
paw injection of CFA (50%, 10 µl). Application of a non-
noxious von Frey fiber to the dorsum of a hind paw elic-
ited no response in untreated wild-type mice, but at one
and three days after CFA injection into the dorsum of a
single hind paw, mice withdrew their hindpaw in
response to stimulation of the ipsilateral or, to a lesser
extent, the contralateral hind paw (Fig. 5A). This mechan-
ical allodynia was significantly reduced in transgenic mice
compared to wild-type mice (n = 5 mice for each group;
Fig. 5A; P < 0.01 as compared between wild-type and
transgenic mice). Similar results were observed in the con-
tralateral hind paw. In wild-type mice, we found a signifi-
cant decrease in hindpaw withdrawal latencies from a
noxious heat source at 1 to 3 days after CFA injection in
the ipsilateral hindpaw (so called thermal hyperalgesia)
(n = 5 mice), and to a lesser extent in the contralateral
hind paw (Fig. 5B). However, thermal hyperalgesia was
significantly reduced in CaMKII transgenic mice (n = 5
mice) compared to wild-type mice (Fig. 5B). To be sure
that the differences in pain behaviors were not attributa-
ble to differences in peripheral inflammation, we meas-
ured hind paw edema in both wild-type and transgenic
mice. A similar degree of inflammation was found in
wild-type and transgenic mice (n = 5 mice for each group,
Fig. 5C), indicating that the peripheral responses to
inflammation are likely identical in these mice.
Our results indicate that the forebrain overexpression of
CaMKII significantly affected synaptic depression in the
ACC in vitro and behavioral sensitization to inflamma-Molecular Pain 2006, 2:21 http://www.molecularpain.com/content/2/1/21
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Long-term potentiation (LTP) and long-term depression (LTD) in ACC slices of wild-type and αCaMKII-F89G transgenic mice Figure 3
Long-term potentiation (LTP) and long-term depression (LTD) in ACC slices of wild-type and αCaMKII-F89G 
transgenic mice. A. Model for the design of αCaMKII-F89G transgenic mice and the selective chemical inhibitor. B. Pro-
longed low frequency stimulation (1 Hz for 15 min) induced LTD of synaptic responses in the ACC of wild-type mice. How-
ever, LTD was abolished in slices of αCaMKII-F89G transgenic mice. Inset: traces of field EPSPs recorded before (Pre) and 
after [22] LTD induction in wild-type and αCaMKII-F89G transgenic mice. C. Similar LTP was induced by theta burst stimula-
tion (TBS) in ACC slices of wild-type and αCaMKII-F89G transgenic mice. D. Summarized results of frequency-dependent 
responses in wild-type and αCaMKII-F89G transgenic mice. The average field EPSPs (% of control) of last 5 min recording (40–
45 min in A) were used for the plot. * P < 0.05 significantly different from wild-type mice.Molecular Pain 2006, 2:21 http://www.molecularpain.com/content/2/1/21
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Behavioral nociceptive responses to noxious heat, mechanical pressure and formalin injection were not altered in αCaMKII- F89G transgenic mice Figure 4
Behavioral nociceptive responses to noxious heat, mechanical pressure and formalin injection were not 
altered in αCaMKII-F89G transgenic mice. A-B. Behavioral nociceptive responses to noxious heating in the tail-flick test 
at two different heating intensities (A) and the hot-plate test at three different temperatures (50, 52, 55°C) (B). No significant 
differences were found between wild-type and αCaMKII-F89G transgenic mice in any test. C-D. No significant differences were 
found in hind paw withdrawal responses to noxious heating or mechanical pressure. E. Behavioral nociceptive responses to 
hindpaw formalin injection, plotted in 5-min intervals, in wild type mice as compared to αCaMKII-F89G transgenic mice. No 
significant difference was found between wild-type and transgenic mice.Molecular Pain 2006, 2:21 http://www.molecularpain.com/content/2/1/21
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Reduction of behavioral sensitization (allodynia) and hyperalgesia after CFA injection in αCaMKII-F89G transgenic mice Figure 5
Reduction of behavioral sensitization (allodynia) and hyperalgesia after CFA injection in αCaMKII-F89G trans-
genic mice. A. The behavioral responses of animals to a non-noxious mechanical stimulus (No. 2.44 von Frey fiber, which 
elicited no response before a dorsal hindpaw CFA injection), were recorded 1 and 3 days after injection. The data were plot-
ted as percentage positive responses to stimulation of the ipsilateral or contralateral hind paw of wild-type and αCaMKII-F89G 
transgenic mice. Inflammation induced less behavioral allodynia in αCaMKII-F89G transgenic mice then wild-type mice (P < 
0.05; indicated by *). B. The behavioral responses of animals to a noxious thermal stimulus were recorded 1 and 3 days after 
the injection. The data were plotted as response latency to stimulation of the ipsilateral or contralateral hind paw of wild-type 
and αCaMKII-F89G transgenic mice. Inflammation induced less hyperalgesia in αCaMKII-F89G transgenic mice then wild-type 
mice (P < 0.05; indicated by *). C. Hindpaw edema was measured with a fine caliper in wild-type and αCaMKII-F89G transgenic 
mice.Molecular Pain 2006, 2:21 http://www.molecularpain.com/content/2/1/21
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tion in vivo. However, we cannot rule out the possibility
that these changes in behavioral responses may due to
developmental, long-term changes in CaMKII-dependent
or related signaling pathways. In the present study, the
chemically engineered mice provide us a chance to turn
off the overexpressed CaMKII activity and examine if the
observed changes can be reversed or 'rescued'. To test this,
we treated CaMKII transgenic mice with the inhibitor
1NM-PP1 for several days to turn off the overexpressed
CaMKII activity. We found that 1NM-PP1 treatment com-
pletely blocked the effects of CaMKII overexpression on
behavioral allodynia and hyperalgesia in transgenic mice
(n = 4–6 mice, see Fig. 6A and 6B, respectively). 1NM-PP1
treatment alone did not significantly affected hindpaw
mechanical withdrawal thresholds (n = 6 mice).
Finally, we tested the effects of 1NM-PP1 on synaptic plas-
ticity to determine if reversing CaMKII over expression
could 'rescue' the loss of synaptic depression induced by 1
Hz repetitive stimulation. As shown in Figure 7, we found
that 1NM-PP1 rescued synaptic depression in the trans-
genic mice (mean 53.2 ± 11.0% of control, n = 7 slices/6
mice, P < 0.05 as compared with transgenic mice). By con-
trast, the inhibitor did not significantly affect baseline
synaptic responses in the ACC slices (n = 6 slices/6 mice)
or synaptic depression in slices of wild-type mice (mean
40.9 ± 12.1% of control, n = 5 slices/5 mice).
Discussion
Our results provide the first evidence that CaMKII activity
in the forebrain plays an important role in cingulate syn-
aptic depression and behavioral sensitization related to
persistent pain after hindpaw inflammation. While our
results do not show a direct correlation between the loss
of synaptic LTD in the ACC and a reduction in behavioral
sensitization in CaMKII transgenic mice, we suggest that
the enhanced forebrain CaMKII activity reduced behavio-
ral sensitization to peripheral injury and that the synaptic
function of CaMKII in cingulate neurons may be one
mechanism contributing to this behavioral phenotype.
Although we focused on the area of the ACC in the current
study, we cannot rule out the possible contribution of
other forebrain areas such as insular cortex and prefrontal
cortex to behavioral changes in the transgenic mice. Our
present findings, together with a previous report of
increased pain behaviors in forebrain NR2B overexpress-
ing mice (Wei et al, 2001), consistently suggest that
behavioral sensitization after tissue injury can be regu-
lated or modulated by neuronal activity within the fore-
brain areas, including the ACC. Loss of LTD in CaMKII
transgenic mice may be responsible for the reduction of
nociceptive responses after tissue injury. The rescuing
effect of 1NM-PP1 in CaMKII transgenic mice provides
strong evidence that the electrophysiological and behav-
ioral changes observed in CaMKII transgenic mice are not
due to any developmental changes induced by CaMKII
overexpression.
The present results provide strong evidence that enhanc-
ing the activity of NMDA receptors or CaMKII does not
have the same consequence on persistent pain despite
being equally implicated in learning-related synaptic plas-
ticity and behavioral memory. We found that forebrain
overexpression of CaMKII did not affect basal nociception
and behavioral nociceptive responses to subcutaneous
injection of formalin. In our previous study in mice over
expressing NMDA NR2B receptors in forebrain regions,
we found that late behavioral nociceptive responses to
formalin was selectively enhanced in transgenic mice [10].
One possible explanation for such a difference is that the
over expressed NMDA NR2B receptors are inactive in nor-
mal conditions due to the magnesium blockade of NMDA
receptors. However, the enhanced activity of CaMKII
would tonically alter the signaling pathways within neu-
rons, including a disruption of normal function and
expression of NMDA receptors in the forebrain. Therefore,
over expressed CaMKII activity within neurons may have
opposite effects on certain outcomes (either at synaptic or
behavioral levels) as compared with NMDA receptors.
Why was behavioral sensitization to injury reduced while
synaptic depression abolished in the ACC CaMKII trans-
genic mice? One major hypothesis for the roles of the ACC
in pain is that neuronal activity in ACC neurons code the
magnitude of pain or pain-related unpleasantness [19].
LTP within the ACC caused by injury or amputation may
in part encode abnormal or enhanced pain sensation [19].
The function of synaptic LTD is always thought to be the
reversed form of LTP; in the case of memory, LTD is pro-
posed to help to erase old memory and thus allow new
memory to form. If we treated plastic changes in the ACC
as a memory event caused by injury (e.g., CFA injection in
this report), we would predict that loss of LTD in the ACC
in CaMKII transgenic mice might abolish the animal's
ability to 'erase' such 'bad' or 'painful' memory. Therefore,
we would predict that behavioral sensitization would be
more likely to be enhanced in CaMKII transgenic mice. By
contrast, we found that behavioral sensitization was
reduced in CaMKII transgenic mice. It is clear that more
experiments are needed in the future to investigate if
changes in NMDA receptor expression and function in the
ACC and other areas in CaMKII transgenic mice may
underlie these results. The roles of cingulate synaptic
depression during the development of behavioral sensiti-
zation remain to explore.
Considering the important roles of CaMKII in neurode-
velopment, it is important to confirm that the phenotypic
changes found in brain slices and in nociceptive behaviors
can be reversed by simply inhibiting the over expressionMolecular Pain 2006, 2:21 http://www.molecularpain.com/content/2/1/21
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Reduction in allodynia and hyperalgesia can be reversed by inhibiting the overexpression of CaMKII activity in αCaMKII-F89G  transgenic mice Figure 6
Reduction in allodynia and hyperalgesia can be reversed by inhibiting the overexpression of CaMKII activity in 
αCaMKII-F89G transgenic mice. A. One-week pretreatment with the inhibitor 1NM-PP1 reversed the reduction of behav-
ioral allodynia in αCaMKII-F89G transgenic mice. No significant difference was found between wild-type mice and αCaMKII-
F89G transgenic mice receiving 1NM-PP1 pretreatment. B. One-week pretreatment with 1NM-PP1 reversed the reduction of 
behavioral hyperalgesia in αCaMKII-F89G transgenic mice. No significant difference was found between wild-type mice and 
αCaMKII-F89G transgenic mice receiving 1NM-PP1 pretreatment.Molecular Pain 2006, 2:21 http://www.molecularpain.com/content/2/1/21
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'Rescued' LTD in αCaMKII-F89G transgenic mice by inhibiting the overexpression of CaMKII activity in αCaMKII-F89G trans- genic mice Figure 7
'Rescued' LTD in αCaMKII-F89G transgenic mice by inhibiting the overexpression of CaMKII activity in αCaM-
KII-F89G transgenic mice. A. One-week pretreatment with 1NM-PP1 reversed the reduction of cingulate LTD in αCaM-
KII-F89G transgenic mice. For comparison, the same plot of αCaMKII-F89G transgenic mice shown in Figure 3 was used. B. 
Summarized data for LTD in wild-type, αCaMKII-F89G transgenic mice, and αCaMKII-F89G transgenic mice with 1NM-PP1 
pretreatment. The average field EPSPs (% of control) of last 5 min recording (40–45 min in A) were used for the plot. * P < 
0.05 as compared with αCaMKII-F89G transgenic mice.Publish with BioMed Central    and   every 
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of CaMKII. In the present study, we found that pretreat-
ment with the inhibitor 1NM-PP1 rescued the loss of
behavioral sensitization as well as synaptic depression in
ACC slices. Therefore, our studies provide strong evidence
for the physiological roles of CaMKII in cingulate neu-
rons, both in terms of selectivity and regional effects.
The present new transgenic mice provide a powerful, and
new tool for investigating the roles of protein kinases in
the expression or maintenance of behavioral sensitiza-
tion. Understanding these molecular and synaptic mech-
anisms hold promise for treating chronic pain in patients.
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